234 related articles for article (PubMed ID: 18314219)
1. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.
Cacoub P; Carrat F; Bédossa P; Lambert J; Pénaranda G; Perronne C; Pol S; Halfon P
J Hepatol; 2008 May; 48(5):765-73. PubMed ID: 18314219
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
Maor Y; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
Haemophilia; 2006 Jul; 12(4):372-9. PubMed ID: 16834736
[TBL] [Abstract][Full Text] [Related]
3. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.
Calès P; Halfon P; Batisse D; Carrat F; Perré P; Penaranda G; Guyader D; d'Alteroche L; Fouchard-Hubert I; Michelet C; Veillon P; Lambert J; Weiss L; Salmon D; Cacoub P
J Hepatol; 2010 Aug; 53(2):238-44. PubMed ID: 20493576
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.
Tural C; Tor J; Sanvisens A; Pérez-Alvarez N; Martínez E; Ojanguren I; García-Samaniego J; Rockstroh J; Barluenga E; Muga R; Planas R; Sirera G; Rey-Joly C; Clotet B
Clin Gastroenterol Hepatol; 2009 Mar; 7(3):339-45. PubMed ID: 19171202
[TBL] [Abstract][Full Text] [Related]
5. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.
Loko MA; Castera L; Dabis F; Le Bail B; Winnock M; Coureau G; Bioulac-Sage P; de Ledinghen V; Neau D;
Am J Gastroenterol; 2008 Aug; 103(8):1973-80. PubMed ID: 18796094
[TBL] [Abstract][Full Text] [Related]
6. Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients.
Bourliere M; Penaranda G; Ouzan D; Renou C; Botta-Fridlund D; Tran A; Rosenthal E; Wartelle-Bladou C; Delasalle P; Oules V; Portal I; Castellani P; Lecomte L; Rosenthal-Allieri MA; Halfon P
Aliment Pharmacol Ther; 2008 Aug; 28(4):458-67. PubMed ID: 18498446
[TBL] [Abstract][Full Text] [Related]
7. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index.
Trang T; Petersen JR; Snyder N
Clin Chim Acta; 2008 Nov; 397(1-2):51-4. PubMed ID: 18692034
[TBL] [Abstract][Full Text] [Related]
9. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.
Sebastiani G; Castera L; Halfon P; Pol S; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
Aliment Pharmacol Ther; 2011 Nov; 34(10):1202-16. PubMed ID: 21981787
[TBL] [Abstract][Full Text] [Related]
10. Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.
Maor Y; Calès P; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
Haemophilia; 2007 Nov; 13(6):722-9. PubMed ID: 17973848
[TBL] [Abstract][Full Text] [Related]
11. [ANRS-fibrovic and homavic: role of non invasive markers of liver fibrosis and insulin resistance during antiviral treatment in HIV-HCV co-infected patients from ANRS HC 02 RIVABIC trial].
Halfon P; Pénaranda G; Cacoub P
Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S113-7. PubMed ID: 19375039
[TBL] [Abstract][Full Text] [Related]
12. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.
Kelleher TB; Mehta SH; Bhaskar R; Sulkowski M; Astemborski J; Thomas DL; Moore RE; Afdhal NH
J Hepatol; 2005 Jul; 43(1):78-84. PubMed ID: 15894397
[TBL] [Abstract][Full Text] [Related]
13. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
[TBL] [Abstract][Full Text] [Related]
14. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.
Halfon P; Bacq Y; De Muret A; Penaranda G; Bourliere M; Ouzan D; Tran A; Botta D; Renou C; Bréchot MC; Degott C; Paradis V
J Hepatol; 2007 Mar; 46(3):395-402. PubMed ID: 17156890
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of diagnostic accuracy of APRI for prediction of fibrosis in hepatitis C patients.
Khan DA; Fatima-Tuz-Zuhra ; Khan FA; Mubarak A
J Ayub Med Coll Abbottabad; 2008; 20(4):122-6. PubMed ID: 19999223
[TBL] [Abstract][Full Text] [Related]
16. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients.
Bottero J; Lacombe K; Guéchot J; Serfaty L; Miailhes P; Bonnard P; Wendum D; Molina JM; Lascoux-Combe C; Girard PM
J Hepatol; 2009 Jun; 50(6):1074-83. PubMed ID: 19398234
[TBL] [Abstract][Full Text] [Related]
17. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
[TBL] [Abstract][Full Text] [Related]
18. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.
Nguyen-Khac E; Chatelain D; Tramier B; Decrombecque C; Robert B; Joly JP; Brevet M; Grignon P; Lion S; Le Page L; Dupas JL
Aliment Pharmacol Ther; 2008 Nov; 28(10):1188-98. PubMed ID: 18705692
[TBL] [Abstract][Full Text] [Related]
19. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C.
Boursier J; de Ledinghen V; Zarski JP; Rousselet MC; Sturm N; Foucher J; Leroy V; Fouchard-Hubert I; Bertrais S; Gallois Y; Oberti F; Dib N; Calès P
Am J Gastroenterol; 2011 Jul; 106(7):1255-63. PubMed ID: 21468012
[TBL] [Abstract][Full Text] [Related]
20. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
